ALNY

#340
Alnylam Pharmaceuticals, Inc. - Common Stock
301.9 7 USD
-0.73%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
297.62
302.68
년간 변동
284.28
495.55
일일 변동
-0.73%
월간 변동
-1.79%
6달 변화
-32.88%
년간 변동율
+5.14%
이전 종가
304.2 0
Open
297.7 2
저가
297.6 2
High
302.6 8
양
1 979
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
손익계산서 대차대조표 현금 흐름
값 Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

뉴스